Vicore Pharma Holding AB listed its shares on Nasdaq and received drug designation from the United States Food and Drug Administration.

The entities involved

• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28
• United States Food and Drug Administration →

  agency of the US Department of Health and Human Services

  • FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09
  • FDA inspection at Unichem Laboratories Limited's Goa facility found procedural enhancements needed, leading to market reaction.Sun 10:21

Related events

• Vicor Corporation listed its stock on the Nasdaq exchange, and the company's CEO, Patrizio Vinciarelli, is facing investor scrutiny regarding sales.Jul 2
• Movado was listed on the Nasdaq stock exchange on September 11, 2026.Sep 12
• Connect Biopharma listed its stock on the Nasdaq exchange on August 1, 2026.Aug 18
• Iovance Biotherapeutics listed its stock on Nasdaq and received Fast Track designation from the FDA.Aug 9
• Vicor Corporation stock is trading on the Nasdaq, and the company's CFO, James Schmidt, has sold company stock.Jun 23